Literature DB >> 4183978

Cholestasis is the result of hypoactive hypertrophic smooth endoplasmic reticulum in the hepatocyte.

F Schaffner, H Popper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4183978     DOI: 10.1016/s0140-6736(69)92704-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Aspects of bile acid metabolism in cystic fibrosis.

Authors:  M C Goodchild; G M Murphy; A M Howell; S A Nutter; C M Anderson
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

2.  Intrahepatic cholestasis as a side-effect of drug therapy.

Authors:  G Feuer; M S Dhami
Journal:  Can Fam Physician       Date:  1982-07       Impact factor: 3.275

Review 3.  Mechanisms and prediction of drug-induced liver disease.

Authors:  P Berthelot
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

4.  Electron microscopic effects of digitonin in normal and cholestatic rat livers.

Authors:  H Scharnbeck; F Schaffner
Journal:  Am J Pathol       Date:  1970-12       Impact factor: 4.307

5.  Stagnation of bile.

Authors: 
Journal:  Br Med J       Date:  1972-09-30

6.  Recent advances in jaundice. Surgical aspects.

Authors:  J L Dawson
Journal:  Br Med J       Date:  1970-01-24

7.  Bilirubin as a cholestatic agent. Physiologic and morphologic observations.

Authors:  C L Witzleben
Journal:  Am J Pathol       Date:  1971-02       Impact factor: 4.307

8.  Bile acid secretion following release of biliary obstruction.

Authors:  U Hyon; M Yoshida
Journal:  Gastroenterol Jpn       Date:  1979-12

9.  Hypertrophic and hypoactive smooth endoplasmic reticulum in hepatocytes uremic patients. A morphometric and biochemical study.

Authors:  S Kawata; K Seki; Y Shinji; S Tarui; T Sugiyama; T Yamano
Journal:  Gastroenterol Jpn       Date:  1982

10.  Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile secretory failure.

Authors:  F R Simon; I M Arias
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.